£4.5M Investment Led by Confluent Medical

Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth    Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »

Congratulations Dr. Sahay!

We congratulate Dr. Priti Sahay (right) from the University of Nottingham with winning the David Meyer Research Price 2024. Dr. Sahay presented her work on our Symatix Membrane at the The European Vision & Eye Research Association 2023 and Nottingham Eye Symposium. Her work is published in Acta Ophthalmologica and can be found here About… Read more »

Biosynthetic Soft Tissue Regeneration Membrane

The Electrospinning Company is excited to announce the development of the second Symatix Technology material. Next to our Symatix Membrane, the world’s first amniotic membrane substitute for ocular surface regeneration, we have started development of a proprietary membrane for use in soft tissue regeneration. The membrane comprises of a synthetic nonwoven structure enriched by medical… Read more »

AWRE 2024, 31 Jan – Feb 1 Ghent, Belgium

The Electrospinning Company will be attending the  AWRE 2024 in Ghent, Belgium, between the 31st and 1st of February.  Our Head of Business Development, Marco Thio, and Senior Scientist Giulia Creed are glad to share their insights into non-woven solutions in abdominal wall reconstruction using electrospinning technology. Book a meeting with them at: info@electrospinning.co.uk

AAOS 2024, 13-15 February San Francisco

The Electrospinning Company will once again exhibit at the AAOS 2024 in San Francisco, US, from 13th to 15th of February.  You are welcome to visit our booth #864 and find out more about our innovative technology. Our CEO, Ann Kramer, Sen. Director of Bus. Dev. North America Jeff Orosco, Head of Business Development, Marco… Read more »

Senior BD hires at The Electrospinning Company to drive growth in key areas. Executives bring more than 30 years’ experience in global medical device companies

Harwell, UK, September 12th, 2023 – The Electrospinning Company, a leading contract research, development and manufacturing organisation for electrospun biomaterials in medical devices, is driving its international expansion with the appointment of two senior business development executives. Conan Campbell, who joins as Senior Director of Business Development, is a specialist in vascular implant coatings. North… Read more »

A Production Technician Intern Journey at TECL

Kinga is currently pursuing a Bachelor of Engineering degree in Medical Engineering at Swansea University in Wales. During her industry placement, she was working as a Production Technician Intern at The Electrospinning Company, where she gained valuable experience in the area of biomaterials science and engineering. As a Production Technician, she collaborated closely with the… Read more »

Ever Congress, Valencia – Spain , October 2023

The Electrospinning Company is delighted to announce its participation in the upcoming EVER Congress scheduled for 26-28 October 2023. During the event, the University of Nottingham will be presenting our ground-breaking Symatix® Membrane in a research paper titled: “A Comparative In Vitro Study: Introducing a Biosynthetic Alternative to Human Amniotic Membrane for Cornea Repair.” This… Read more »